An evolving understanding of the interactions between sleep and Aβ metabolism in the non-DS brain suggests that the interplay between APP gene dosage and OSAS in DS might set in motion cycles of progressively worse developmental and cognitive outcomes. The gene discussed is APP; the disease is Dravet syndrome.